3H-Pyrazolo[3,4-B]pyridine | 271-72-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3H-Pyrazolo[3,4-B]pyridine
• CAS: 271-72-7
• 化学式: C₆H₅N₃
• 分子量: 119.12
• InChiKey: KRTUUHNZXSGCBS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  37.6
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
  申请人：SU Wei-Guo

  公开号：US20120245178A1

  公开（公告）日：2012-09-27

  Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.

  提供了某些三唑吡啶和三唑吡嗪，以及它们的组成物和使用方法。
• COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
  申请人：Plexxikon Inc.

  公开号：US20170157120A1

  公开（公告）日：2017-06-08

  Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

  描述了对蛋白激酶活性有影响的化合物，以及制备和使用这些化合物来治疗与蛋白激酶异常活性相关的疾病和症状的方法。
• [EN] PROCESS FOR THE MODIFICATION OF A GLYCOPROTEIN USING A ΒETA-(1,4)-N-ACETYLGALACTOSAMINYLTRANSFERASE OR A MUTANT THEREOF<br/>[FR] PROCÉDÉ POUR LA MODIFICATION D'UNE GLYCOPROTÉINE À L'AIDE D'UNE BÊTA-(1,4)-N-ACÉTYLGALACTOSAMINYL-TRANSFÉRASE OU D'UN MUTANT CORRESPONDANT
  申请人：SYNAFFIX BV

  公开号：WO2016022027A1

  公开（公告）日：2016-02-11

  The present invention relates to a process for the modification of a glycoprotein, using a β-(1,4)-N-acetylgalactosaminyltransferase or a mutant thereof.The process comprisesthe step of contacting a glycoprotein comprising a glycan comprising a terminal GlcNAc-moiety, in the presence of a β-(1,4)-N-acetylgalactosaminyl- transferase or a mutant thereof, with anon-natural sugar-derivative nucleotide.The non-natural sugar-derivative nucleotideis according to formula (3), wherein A is selected from the group consisting of -N3; -C(0)R3; -C=C-R4; -SH; -SC(0)R8; -SC(V)OR8, wherein V is O or S; -X wherein X is selected from the group consisting of F, CI, Br and I; -OS(0)2R5; an optionally substituted C2 - C24 alkyl group; an optionally substituted terminal C2 - C24 alkenyl group; and an optionally substituted terminal C3 - C24 allenyl group.

  本发明涉及一种修饰糖蛋白的过程，使用β-(1,4)-N-乙酰半乳糖氨基转移酶或其突变体。该过程包括以下步骤：在β-(1,4)-N-乙酰半乳糖氨基转移酶或其突变体存在下，将含有末端GlcNAc基团的糖蛋白与一种非天然糖衍生核苷酸接触。该非天然糖衍生核苷酸符合以下公式(3)，其中A选自-N3；-C(0)R3；-C=C-R4；-SH；-SC(0)R8；-SC(V)OR8，其中V为O或S；-X，其中X选自F、CI、Br和I；-OS(0)2R5；一个可选择取代的C2-C24烷基团；一个可选择取代的末端C2-C24烯基团；和一个可选择取代的末端C3-C24烯丙基团。
• ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS
  申请人：CUI Jingrong Jean

  公开号：US20140288086A1

  公开（公告）日：2014-09-25

  Enantiomerically pure compound of formula 1 are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.

  本发明提供了公式1的对映纯化合物，以及它们的合成和使用方法。首选化合物是c-Met蛋白激酶的强效抑制剂，可用于治疗异常细胞增生性疾病，例如癌症。
• 6H-THIENO[2,3-b]PYRROLE DERIVATIVES AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE (GNRH)
  申请人：Foote Michael Kevin

  公开号：US20080045517A1

  公开（公告）日：2008-02-21

  The invention relates to a group of novel thieno-pyrrole compounds of Formula (I): wherein: R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.

  该发明涉及一组新型噻吩-吡咯化合物，其化学式为(I)：其中：R1、R2、R3、R4和R5如规范中所定义，这些化合物可用作促性腺激素释放激素拮抗剂。该发明还涉及该化合物的制药配方、使用该化合物的治疗方法以及制备该化合物的过程。